Unitree Robotics IPO targets $618M raise on Shanghai bourse
Synopsis
Unitree Robotics — one of the few profitable players in China's embodied AI boom — has won CSRC approval to raise US$618.4 million on the Shanghai Stock Exchange, setting a valuation benchmark for a sector flooded with venture capital but short on profits.
Key Takeaways
Unitree Robotics has received China Securities Regulatory Commission (CSRC) approval for a Shanghai Stock Exchange IPO, targeting a debut as early as late July 2026 .
The company plans to raise approximately 4.2 billion yuan (US$618.4 million) by selling at least 40.4 million shares , representing a minimum 10 per cent stake and implying a valuation of around 42 billion yuan .
Unitree reported 1.7 billion yuan in revenue and 591 million yuan in adjusted profit last year, making it a rare profitable entity in the embodied AI space.
Rival UBTech Robotics , listed in Hong Kong , posted 2 billion yuan in revenue but a net loss of roughly 700 million yuan , with a market cap of approximately HK$52.8 billion (US$6.7 billion) .
IPO proceeds will fund robot model development, robot-body research, new products, and manufacturing capacity expansion, according to the company's prospectus.
Unitree Robotics, the Hangzhou-based humanoid robot maker, has received regulatory clearance from the China Securities Regulatory Commission (CSRC) to list on the Shanghai Stock Exchange, setting the stage for what could become a landmark valuation test for China's embodied AI sector. The company is targeting a raise of approximately 4.2 billion yuan (US$618.4 million) and could debut as early as late July 2026.
The IPO Structure
Unitree plans to sell a minimum of 40.4 million shares, representing at least a 10 per cent stake, implying an initial valuation of roughly 42 billion yuan. The CSRC approval came approximately one month after the company cleared a listing committee review at the Shanghai Stock Exchange. The company is now finalising its underwriting plan, pricing, and share subscription process.
According to its prospectus, proceeds will be directed toward robot model development, robot-body research, new product lines, and expanded manufacturing capacity.
Why It Matters: A Rare Profitable Player
Unitree's financials stand out in a sector where losses are common. The company posted 1.7 billion yuan in revenue and 591 million yuan in adjusted profit in the last reported fiscal year — a combination that is uncommon among its peers in the embodied AI space.
By contrast, Hong Kong-listed rival UBTech Robotics reported 2 billion yuan in revenue over the same period but recorded a net loss of approximately 700 million yuan. UBTech's market capitalisation stood at around HK$52.8 billion (US$6.7 billion) as of the most recent trading session.
The Competitive Backdrop
Venture capital has flooded China's robotics ecosystem, with firms including Galaxea AI, Galbot, AI² Robotics, Linkerbot, TARS, JoyIn, and Spirit AI all competing for market share and investor attention. Strategic backing from technology conglomerates — among them Alibaba Group Holding and Ant Group — has further intensified the race to commercialise humanoid and industrial robots.
The Unitree listing will serve as a critical pricing reference for private-market valuations across this crowded field, with investors in Shenzhen and Suzhou-based startups watching closely.
What's Next
With underwriting and pricing still being finalised, a late July 2026 debut remains the target window, though timelines can shift during the subscription phase. The offering's reception will likely influence the pace at which other embodied AI startups pursue their own public listings in China and Hong Kong. Investors and industry observers will be watching whether the market assigns Unitree a premium over loss-making peers — and by how much.
Point of View
But Unitree's profitability could force a rational re-rating across the sector. What mainstream coverage underplays is the regulatory signal: the CSRC fast-tracking this listing suggests Beijing views domestic robotics champions as strategic infrastructure, not merely commercial ventures. The real stress test comes at pricing — if Unitree commands a premium over UBTech on a per-revenue basis, expect a wave of follow-on listings from VC-backed peers currently burning cash in Shenzhen and Suzhou.
NationPress
3 Jul 2026
Frequently Asked Questions
What is the Unitree Robotics IPO and when will it happen?
Unitree Robotics has received approval from China 's securities regulator to list on the Shanghai Stock Exchange , targeting a debut as early as late July 2026 . The company is finalising its underwriting, pricing, and share subscription process following CSRC clearance.
How much is Unitree Robotics looking to raise in its IPO?
Unitree Robotics plans to raise approximately 4.2 billion yuan (US$618.4 million) by selling at least 40.4 million shares . This represents a minimum 10 per cent stake, implying an initial valuation of around 42 billion yuan .
Is Unitree Robotics profitable?
Yes — Unitree Robotics generated 1.7 billion yuan in revenue and 591 million yuan in adjusted profit last year, making it a rare profitable company in China 's embodied AI sector. This contrasts sharply with loss-making peers such as UBTech Robotics .
How does Unitree compare to UBTech Robotics?
UBTech Robotics , listed in Hong Kong , reported higher revenue of 2 billion yuan last year but posted a net loss of roughly 700 million yuan , with a market capitalisation of approximately HK$52.8 billion (US$6.7 billion) . Unitree 's profitability gives it a distinct financial profile heading into its public debut.
Why does the Unitree IPO matter for China's robotics sector?
The Unitree listing is expected to set a valuation benchmark for China 's broader embodied AI industry, which has attracted heavy venture capital from firms and conglomerates including Alibaba Group Holding and Ant Group . Its market reception will likely determine how quickly other robotics startups pursue their own public listings.
